IP Library Granted Patent US 7,667,091
Granted Patent B2
US 7,667,091 · App. 10/471,960 · Granted Feb 23, 2010

Method of encoding information in nucleic acids of a genetically engineered organism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,667,091
App. No.
10/471,960
Granted
Feb 23, 2010
Kind
B2
Abstract

The present invention provides a method of producing a genetically engineered transgenic organism, by (a) incorporating into the organism a functional DNA sequence that confers a trait on an organism and (b) incorporating into the organism a non-functional DNA sequence, wherein the non-functional DNA sequence encodes an information message using a predefined coding scheme, wherein the information message provides information about the functional DNA sequence, and the predefined coding scheme can be used to map a plurality of information messages into a plurality of non-functional DNA sequences and additionally, the functional and the non-functional DNA sequence are incorporated into the same chromosome of the organism.

Claims (31)

1. A method of producing a genetically engineered transgenic non-human organism comprising:

(a) incorporating into a non-human organism a functional DNA sequence that confers a trait on said organism; and

(b) incorporating into said organism a non-functional DNA sequence,

wherein said non-functional DNA has no function in the organism other than that of providing information about said functional DNA, further wherein

(i) said non-functional DNA sequence encodes an information message using a predefined coding scheme; and

(ii) said information message provides information about said functional DNA sequence, and

wherein said functional DNA sequence of (a) above and said non-functional DNA sequence of (b) above are incorporated into the same chromosome of said organism, thereby producing a genetically engineered transgenic non-human organism.

2. The method according to claim 1 , wherein said functional DNA sequence is incorporated into said organism prior to said non-functional DNA sequence.

3. The method according to claim 1 , wherein said non-functional DNA sequence is incorporated into said organism prior to said functional DNA sequence.

4. The method according to claim 1 , wherein said non-functional DNA sequence and said functional DNA sequence are incorporated into said organism simultaneously.

5. The method according to claim 1 , wherein said non-functional DNA sequence and said functional DNA sequence are located sufficiently close on said chromosome to prevent separation by recombination.

6. The method according to claim 1 , wherein said non-functional DNA sequence is an intron or encodes an intein.

7. The method according to claim 6 , wherein the intron or intein-encoding sequence is placed within the related functional DNA sequence.

8. The method according to claim 7 , wherein the intron or intein-encoding sequence is placed within a conserved portion of the related functional DNA sequence.

9. The method according to claim 1 , wherein said non-functional DNA sequence, optionally in conjunction with a spacer DNA sequence between said non-functional DNA sequence and said functional DNA sequence, is chosen such that it is not able to form secondary structures and/or such that it is free of recombination or mutation hot spots.

10. The method according to claim 1 , wherein said mapping is from DNA portions to alphanumeric characters.

11. The method according to claim 1 , wherein said predefined coding scheme translates DNA triplets to alphanumeric characters.

12. The method according to claim 1 , wherein said non-functional DNA sequence comprises at least one pre-defined recognition sequence that allows for identification and/or analysis of said non-functional DNA sequence.

13. The method according to claim 12 , wherein said non-functional DNA sequence is flanked at least on one side by the recognition sequence.

14. The method according to claim 12 , wherein said pre defined recognition sequence comprises joint and/or separate recognition of multiple non-functional DNA sequences in the organism.

15. The method according to claim 12 , wherein said pre defined recognition sequences are placed such to allow PCR amplification of said functional DNA sequence or portions thereof using primers complementary to said pre-defined recognition sequences.

16. The method according to claim 12 , wherein said pre defined recognition sequence comprises joint and/or separate recognition of multiple non-functional DNA sequences in the organism.

17. The method according to claim 1 , wherein the functional DNA sequence is flanked on both sides by portions of said non-functional DNA sequence.

18. The method according to claim 1 , wherein said non-functional DNA sequence contains an additional DNA sequence encoding an expressible polypeptide for quick detection.

19. The method according to claim 1 , wherein the information message comprises a trademark, a reference to a database, a date, a place, the name of a producer or an owner, or an indication of the presence and/or position of said functional DNA sequence, or any combination thereof.

20. The method according to claim 1 , wherein said non-functional DNA sequence does not adversely affect the performance of said functional DNA sequence in said genetically engineered organism.

21. The method according to claim 1 , wherein said incorporation into said organism of said non-functional DNA sequence does not adversely affect the genetic stability of said non-functional and/or said functional DNA sequence and/or the incorporation of said non-functional and said functional DNA sequence into the same chromosome of said organism.

22. The method according to claim 1 , wherein the organism is a plant.

23. The method according to claim 1 , wherein the organism is an animal.

24. The method according to claim 1 , wherein said predefined coding scheme can be used to map a plurality of information messages to a plurality of said non-functional DNA sequences.

25. The method according to claim 1 , wherein using said predefined coding scheme, said information message can be non-uniquely mapped to multiple non-functional DNA sequences and said nonfunctional DNA sequence can be uniquely mapped to said information message.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2019
From: BAYER CROPSCIENCE NV; BAYER CROPSCIENCE SA-NV
To: BASF AGRICULTURAL SOLUTIONS SEED, US LLC
Reel/Frame 049124/0894 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL/FRAME 029170/0252 . THE ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT OF THE ENTIRE INTEREST. Recorded Apr 3, 2013
From: BAYER BIOSCIENCE N. V.
To: BAYER CROPSCIENCE N. V.
Reel/Frame 030148/0678 →
CORRECTIVE: REEL/FRAME: 029162/0604 CORRECTING NAME ADDRESS OF RECEIVING PARTY TO "BAYER BIOSCIENCE N.V., TECHNOLOGIEPARK 38, 9052 GENT, BELGIUM" Recorded Apr 3, 2013
From: ICON GENETICS GMBH
To: BAYER BIOSCIENCE N. V.
Reel/Frame 030148/0874 →
MERGER Recorded Oct 19, 2012
From: BAYER BIOSCIENCE N.V.
To: BAYER CROPSCIENCE N.V.
Reel/Frame 029170/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2012
From: ICON GENETICS GMBH
To: BAYER CROPSCIENCE N.V.
Reel/Frame 029162/0604 →
MERGER Recorded Jun 15, 2007
From: ICON GENETICS AG
To: ICON GENETICS GMBH
Reel/Frame 019439/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2004
From: GLEBA, YURI; KLIMYUK, VICTOR
To: ICON GENETICS AG
Reel/Frame 014493/0716 →